Gene Security Network Decodes $6M

Redwood City-based Gene Security Network, which develops molecular diagnostics technology to enhance genetic testing, said Wednesday that it has closed on a $6M Series B funding round. The new funding came from current investors Claremont Creek Ventures and Sequoia Capital, along with new investor Alafi Capital. Gene Security Network is developing diagnostics used for genetic testing during in-vitro fertilization. The firm raised a $4M, Series A round in December of 2007. More information »